Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression analysis of VMRC-LD cells transfected with siRNA against DRAIC

ABSTRACT: DRAIC is a long non-coding RNA, that is involved in various cancer progressions. We performed gene expression microarray after DRAIC knockdown in VMRC-LCD cells to reveal the potential downstream genes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE242691 | GEO | 2023/12/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression analysis of VMRC-LD cells transfected with siRNA against DRAIC

Project description:Gene expression analysis of VMRC-LD cells transfected with siRNA against DRAIC

| PRJNA1014124 | ENA

Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells.

Project description:The goal of this study is to examine the effect of DRAIC knockdown on the MCF-7 transcriptome.

2019-03-18 | GSE118101 | GEO

Gene expression analysis of NCI-H727 cells transfected with siRNA against PROX1

Project description:This study aimed to reveal downstream genes of PROX1 in a carcinoid-derived cell line NCI-H727. We performed gene expression microarray after PROX1 knockdown in NCI-H727 cells.

2024-07-28 | GSE268379 | GEO

Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells.

Project description:Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells.

| PRJNA484404 | ENA

DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression

Project description:Both N6-methyladenosine (m6A) mediates RNA fates and ubiquitin mediates protein fates play an important role in either physiology or pathology including cancer, yet how long noncoding RNAs (lncRNAs) are involved in a link of molecular fate between m6A and ubiquitin remains unknown. Here, we reveal a role for a lncRNA Downregulated RNA in Cancer (DRAIC) to suppress tumor growth and metastasis in clear cell Renal Carcinoma (ccRCC). Mechanistically, DRAIC physically interacts with heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) and enhances its protein stability by blocking E3 ligase F-box protein 11 (FBXO11)-mediated ubiquitin and proteasome-dependent degradation. Subsequently, hnRNPA2B1 destabilizes m6A modified-type 1 insulin-like growth factor receptor (IGF1R) to lead to inhibition of ccRCC progression. Moreover, four m6A modification sites of IGF1R are identified and results in its mRNA degradation. Collectively, our findings reveal that DRAIC/hnRNPA2B1 axis regulates IGF1R mRNA expression in an m6A-dependent manner and highlights an important mechanism of IGF1R fate. These findings shed light on DRAIC/hnRNPA2B1/FBXO11/IGF1R axis as potential therapeutic targets in ccRCC and build a link of molecular fate between m6A-modified RNA and ubiquitin-modified protein.

2024-04-26 | GSE262500 | GEO

DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression [m6A-seq]

2024-01-07 | GSE244892 | GEO

DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression [RNA-seq]

2024-01-07 | GSE244891 | GEO

Human MCF7 cells: Mock control vs. siRNA transfected against calreticulin

Project description:Transcriptional profiling of human MCF7 cells comparing mock control MCF7cells with MCF7cells transfected by siRNA against calreticulin. The latter was shown to be of having significantly decreased expression of calreticulin followed by significant decrease in migrative and invasive potentials of the MCF7 cells. Goal was to determine the effect of calreticulin knockdown on the global gene expression of MCF7 cells.

2013-02-26 | GSE44371 | GEO

Human MCF7 cells: Mock control vs. siRNA transfected against calreticulin

2013-02-26 | E-GEOD-44371 | biostudies-arrayexpress